DC Funds
Latest statistics and disclosures from DC Funds's latest quarterly 13F-HR filing:
- Top 5 stock holdings are TCRX, HOWL, BRNS, and represent 100.00% of DC Funds's stock portfolio.
- DC Funds has $6.0M in assets under management (AUM), dropping by -41.81%.
- Central Index Key (CIK): 0001869028
Tip: Access up to 7 years of quarterly data
Positions held by DC Funds consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for DC Funds
DC Funds holds 3 positions in its portfolio as reported in the June 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Tscan Therapeutics (TCRX) | 61.2 | $3.7M | 630k | 5.85 |
|
|
| Werewolf Therapeutics (HOWL) | 23.9 | $1.4M | 589k | 2.44 |
|
|
| Barinthus Biotherapeutics Pl Ads (BRNS) | 14.9 | $899k | 642k | 1.40 |
|
Past Filings by DC Funds
SEC 13F filings are viewable for DC Funds going back to 2021
- DC Funds 2024 Q2 filed Aug. 13, 2024
- DC Funds 2024 Q1 filed May 14, 2024
- DC Funds 2023 Q4 filed Feb. 13, 2024
- DC Funds 2023 Q3 filed Nov. 14, 2023
- DC Funds 2023 Q2 filed Aug. 10, 2023
- DC Funds 2023 Q1 filed May 15, 2023
- DC Funds 2022 Q4 filed Feb. 14, 2023
- DC Funds 2022 Q3 filed Nov. 14, 2022
- DC Funds 2022 Q2 filed Aug. 12, 2022
- DC Funds 2022 Q1 filed May 13, 2022
- DC Funds 2021 Q4 filed Feb. 11, 2022
- DC Funds 2021 Q3 filed Nov. 12, 2021
- DC Funds 2021 Q2 restated filed Aug. 23, 2021
- DC Funds 2021 Q2 filed Aug. 13, 2021